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The Apelin pathway has only recently emerged as an important regulator of cardiac and vascular
function, mediating adaptation to physiological stress and disease. In this issue of Developmental
Cell, experiments in zebrafish convincingly show a critical role for this pathway in myocardial cell
specification and heart development (Scott et al., 2007; Zeng et al., 2007).The G protein-coupled receptor
(GPCR) angiotensin receptor-like 1b
(agtrl1b, X-msr, APJ) was cloned ini-
tially by sequence homology through
efforts aimed at characterizing novel
proteins of this class (Lee et al.,
2006). Unique features of this gene in-
cluded a highly restricted endothelial
cell expression pattern and a concep-
tual protein sequence most similar to
the angiotensin II type 1a receptor,
a molecule that had been extensively
studied in the context of cardiovascu-
lar physiology. Years later, after the
ligand for this receptor (Apelin) was
cloned in other species, its expression
pattern was also shown to be re-
stricted to endothelial cells, although
appearing primarily in cells at sites
of active vascular growth (Cox et al.,
2006; Saint-Geniez et al., 2002). These
observations suggested the hypothe-
sis that autocrine signaling of this
pathway in endothelial cells provides
a mechanism for regulating new
blood vessel growth, or angiogenesis.
Recent loss-of-function experiments
in frog embryos employing morpholino
knockdown experiments have consis-
tently shown vascular developmental
abnormalities, varying from perturbed
intersomitic vessel branching to more
fundamental developmental defects,
including decreased numbers of endo-
thelial cells (Cox et al., 2006; Inui et al.,
2006). Interestingly, one laboratory
also described severe cardiac defects
in frog embryos with depletion of
agtrl1b, but they interpreted these
defects as secondary to the primary
endothelial effects (Inui et al., 2006).Activation of this pathway in cultured
endothelial cells has been shown to
promote migration and proliferation,
and blood vessel growth-promoting
functions of apelin have been demon-
strated in angiogenesis assays (Cox
et al., 2006). Thus, previous studies
have identified an early role for this
pathway in endothelial cell biology
and vascular development.
In the adult, cardiovascular Apelin
expression is restricted to theendothe-
lium of small vessels, and the agtrl1b
receptor is found on both endothelial
cells and possibly some smooth mus-
cle cells in the vasculature as well as
on myocardial cells. In blood vessels
this pathway mediates regulation of
hemodynamics on both the arterial
and venous sides of the circulation
(Lee et al., 2006). Most important for
thisdiscussion, thispathway isapotent
endogenous activator of contractile
function, as documented by experi-
ments in isolated organ preparations
and in in vivomodels of normal and fail-
ing hearts (Ashley et al., 2005; Szokodi
et al., 2002). The positive inotropic
effect is unique in that it appears to
not have the detrimental hypertrophic
effect seen with sustained activation
of other pathways that increase con-
tractile function, suggesting a unique
signaling mechanism in the heart.
In the current issue of Developmen-
tal Cell, two laboratories have em-
ployed the power of the zebrafish
developmental model to prove with
elegant studies that Apelin serves as
a critical gradient for migration of me-
sodermal cells fated to contribute toDevelopmental Cellthe myocardial lineage (Scott et al.,
2007; Zeng et al., 2007). Zebrafish pre-
gastrulae embryos were shown to ex-
press agtrl1b early in the blastoderm
margin and later in regions where heart
precursors reside, and Apelin ligand
expression was shown to be restricted
to the midline. Depletion of the agtrl1b
receptor resulted in a reduced number
of myocardial progenitor cells and
the absence of an organized cardiac
structure. Surprisingly, the introduc-
tion of excess Apelin was found to im-
pair gastrulation and entirely abrogate
myocardial cell differentiation. This lat-
ter finding suggested that loss of a lo-
calized source of Apelin did not allow
cells fated to form the myocardium to
reach their appointed location. This
hypothesis was confirmed by cell
tracing experiments showing that an
excess or deficit of Apelin impaired
convergence and extension move-
ments of the heart precursors. Taken
together, these data strongly suggest
that the Apelin-agtrl1b pathway medi-
ates migration of myocardial progeni-
tors to the correct position in the ante-
rior lateral plate mesoderm, and that
disruption of this pathway leads to de-
fective migration, loss of critical induc-
tive differentiation signals, and failure
of differentiation of myocardial pro-
genitor cells. Interestingly, these stud-
ies in zebrafish documented expres-
sion of agtrl1b receptor in endothelial
cells associated with the heart and
major vessels, but did not find evi-
dence of disrupted vascular develop-
ment in experiments where agtrl1b or
Apelin expression was perturbed.12, March 2007 ª2007 Elsevier Inc. 319
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PreviewsAs thorough as these studies have
been, there are issues that remain to
be clarified. First, it is not clear whether
loss of Apelin expression produces
a cardiac phenotype similar to that
observed with decreased agtrl1b. Al-
though there are two agtrl1 genes in
zebrafish, there is only one Apelin
gene, so loss of this gene should phe-
nocopy the agtrl1b depletion/mutation
phenotype. A difference in phenotypes
might imply that another agtrl1b ligand
can compensate for loss of Apelin, at
least in heart development. Interest-
ingly, while targeted deletion of the
agtrl1b gene in mice produces marked
cardiac defects, preliminary analyses
of mice lacking Apelin do not show
these defects. Second, one of the ze-
brafish papers characterized the phe-
notype of embryos carrying a germline
mutation in agtrl1b (grinch) and re-
ported that only about half of the
embryos with this mutation exhibited
the defective cardiac phenotype. Sim-
ilarly, only half of mouse embryosSpecial Delivery:
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Gap junction formation depends
cell contact. Recently in Cell, Sha
of connexin43 to adherens juncti
geted delivery of membrane prot
The dynamic nature of microtubules
in eukaryotic cells suggests that sto-
chastic cycles of growth and shrinkage
are used to explore cellular space. This
has lead to a search andcapturemodel
in which the randomly directed out-
growth of a microtubule may lead to
an encounter with a binding target. In-
teraction with the target protein may
preferentially stabilize that micro-
320 Developmental Cell 12, March 2007homozygous null for agtrl1b show the
developmental cardiac phenotype.
These data are most consistent with
stochastic compensation by an alter-
native pathway that can functionally
compensate for loss of the Apelin-
agtrl1b pathway. While this is likely an-
other GPCR pathway, its identity re-
mains unknown, the subject for further
study. Third, while studies in frog and
mice have suggested that the Apelin-
agtrlb1 pathway is required for vas-
cular development, neither of these
papers identified such defects. This
may reflect a focus on early develop-
mental events or a fundamental differ-
ence in zebrafish physiology, but it
deserves further study. Finally, it is
unclear why only cardiac development
is severely affected, since the receptor
is found in most mesodermal precur-
sors. Answers to these questions will
likely further highlight the unique as-
pects of this pathway that regulates
development and function of the
cardiovascular system.Dynamic Targeti
tubules
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on the proper transport of conne
w et al. implicate microtubule tip t
ons (Shaw et al., 2007). This findin
eins by microtubule capture at the
tubule, while other microtubules that
are not captured will be more likely to
undergo catastrophe. Such a mecha-
nism would lead to the transient stabi-
lization of microtubules that can serve
as preferential tracks for intracellular
transport.
The cortical capture of microtubules
would provide a direct link between
the cell center and its periphery, and
ª2007 Elsevier Inc.REFERENCES
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xin hemichannels to sites of cell-
racking proteins in the trafficking
g suggests a mechanism for tar-
cortex.
thus serve to increase the efficiency
of intracellular trafficking to the plasma
membrane. Further, if the targeting
is polarized, then the cell will have a
mechanism to direct the delivery of
materials, such as newly synthesized
proteins and lipids, from the Golgi to
specific sites at the cortex.
One possible target for polarized
delivery is the adherens junction.
